Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116512) titled 'A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants' on Aug. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Bayer
Condition:
Heart Failure With Left Ventricular Ejection Fraction Greater Than or Equal to 40 Per Cent
Healthy Volunteers
Intervention:
Drug: Finerenone (BAY94-8862): intervention A
Recruitment Status: Not recruiting
Phase: Phas...